Key Points Unlearn will apply AI modeling to existing data from Structure Therapeutics’ completed ACCESS open-label extension study of aleniglipron. The analysis will estimate how…
November 12, 2026
October 14, 2026
Viking Therapeutics Launches Phase 3 SUNRISE Program for Once-Daily Oral VK2735 in Obesity
Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, announced on October 14, 2026 that it has started the…
With an oncology program entering a registrational study and positive data from an oral obesity candidate, Corbus heads into the fourth quarter with two clinical…
September 22, 2026
PRISM Mid-Day Movers: Weight Loss and Pet Care are Today’s Leaders.
Viking Therapeutics, Inc. (NASDAQ: VKTX) is up today, surging to 28.47% to $38.6814 after reaching an intraday high of $41.1299, with 27.70 million shares traded—more…
September 22, 2026
Viking Therapeutics Holds 90% of Weight Loss on Monthly Dosing, Answering the Question the Obesity Market Keeps Asking
Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage company developing therapies for metabolic and endocrine disorders, announced on September 22, 2026 topline results from the VK2735-102…
Corbus Pharmaceuticals received FDA clearance to start its TEMPO‑1 registrational trial. Registrational studies are designed to provide the pivotal data needed to support a future…
Allurion Technologies Inc. (ticker: ALUR) is ripping higher again today, with the stock up about 36% to 4.00 from a prior close of 2.94. Shares…
Allurion Technologies Inc. (OTC: ALUR) is experiencing an extreme, low‑float style melt‑up today, with the stock rocketing 1,189.7% to 7.48 from a prior close of…
May 28, 2026
Kailera Therapeutics, Inc. Follows a Validated Biological Path in the Lucrative Weight Loss Sector
Kailera Therapeutics, Inc. (NASDAQ: KLRA) recently completed a record-breaking initial public offering to fund its advanced metabolic pipeline. This historic market debut for Kailera Therapeutics…
Hims & Hers Health (NYSE: HIMS) reported first-quarter results that show a company navigating a deliberate reset in its weight-loss business. Revenue grew, subscribers grew,…
Shares of Hepion Pharmaceuticals, Inc. (OTC: HEPA) are moving higher, with the stock up about 23% today to $0.0503 as very light absolute dollar flows translate into large percentage…
Shares of Maxeon Solar Technologies, Ltd. (NASDAQ: MAXN) are surging, up about 54%, as traders pile back into the beaten‑down solar manufacturer on renewed speculation around financing…